For the Inventor, By the Inventor

Enter assignee name

Raritan, NJ, United States of America

Veridex, Lcc

USPTO Granted Patents = 24

% Expired Patents = 50.0

CIPO Patents = 18

EPO Patents = 6

Forward Citations = 845

Loading Chart...

Loading Chart...

46 inventors (with patents filed for the assignee):

Leon W M M Terstappen (10 out of 25 patents)

Arjan G J Tibbe (7 out of 10 patents)

Jan Greve (5 out of 9 patents)

4. Yixin Wang (5 out of 6 patents)

5. Galla Chandra Rao (4 out of 21 patents)

6. Frank P Modica (4 out of 4 patents)

7. John A Verrant (4 out of 12 patents)

8. Herman Rutner (3 out of 5 patents)

9. Madeline I Repollet (3 out of 3 patents)

10. Frank A W Coumans (3 out of 3 patents)

11. Mark Carle Connelly (2 out of 15 patents)

12. Shawn Mark O'Hara (2 out of 5 patents)

13. Steven Gross (2 out of 4 patents)

14. Michael Kagan (2 out of 5 patents)

15. Jerry Prohaska (2 out of 5 patents)

24 patents: Sort by Forward Citations

1. 8940493 - Circulating tumor cell assay (2015-01-27),

2. 8569077 - Imaging of immunomagnetically enriched rare cells (2013-10-29),

3. 8337755 - Operator independent programmable sample preparation and analysis system (2012-12-25),

4. 8329422 - Analysis of circulating tumor cells, fragments, and debris (2012-12-11),

5. 8189899 - Methods and algorithms for cell enumeration in a low-cost cytometer (2012-05-29),

6. 8183353 - Breast cancer prognostics (2012-05-22),

7. 8128890 - Methods and algorithms for cell enumeration in a low-cost cytometer (2012-03-06),

8. 8110101 - Method and apparatus for imaging target components in a biological sample using permanent magnets (2012-02-07),

9. 7943397 - Methods and algorithms for cell enumeration in low-cost cytometer (2011-05-17),

10. 7932036 - Methods of determining acute myeloid leukemia response to treatment with farnesyltransferase (2011-04-26),

11. 7927805 - Process for predicting the prognosis of squamous cell lung cancer (2011-04-19),

12. 7901950 - Method for assessing disease states by profile analysis of isolated circulating endothelial cells (2011-03-08),

13. 7863012 - Analysis of circulating tumor cells, fragments, and debris (2011-01-04),

14. 7828968 - Method and apparatus for imaging target components in a biological sample using permanent magnets (2010-11-09),

15. 7815863 - Cartridge for containing a specimen sample for optical analysis (2010-10-19),

Veridex, LLC, based in Raritan, NJ, specializes in the development of advanced diagnostic solutions, particularly in the field of oncology. The company focuses on innovative technologies that enhance the detection and monitoring of cancer, aiming to improve patient outcomes through precision medicine. With a commitment to research and development, Veridex leverages cutting-edge methodologies to provide healthcare professionals with tools that facilitate early diagnosis and effective treatment strategies.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

24 Patents

#7 in Raritan, NJ

#540 in New Jersey

#13,859 in US

#26,595 in the World

Raritan, NJ, United States of America

Veridex, Lcc

Forward Citations = 845

46 inventors:

Leon W M M Terstappen (10 out of 25 patents)

Arjan G J Tibbe (7 out of 10 patents)

Jan Greve (5 out of 9 patents)

4. Yixin Wang (5 out of 6 patents)

5. Galla Chandra Rao (4 out of 21 patents)

Please report any incorrect information to [email protected]

Loading…